Seven customers reported cartridge performance with a higher number of invalid results than would typically be expected with the kit and its intended use specimen types. Cepheid investigated the complaints and found that the complaints were valid. The failure investigation identifies six kit lots that were affected. Only one of the lots were imported and sold in Canada.